ABSTRACT
DNA damage induced by ultraviolet (UV) radiation can be removed by nucleotide excision repair through two sub-pathways, one general (GGR) and the other specific for transcribed DNA (TCR), and the processing of unrepaired lesions trigger signals that may lead to cell death. These signals involve the tumor suppressor p53 protein, a central regulator of cell responses to DNA damage, and the E3 ubiquitin ligase Mdm2, that forms a feedback regulatory loop with p53. The involvement of cell cycle and transcription on the signaling to apoptosis was investigated in UVB-irradiated synchronized, DNA repair proficient, CS-B (TCR-deficient) and XP-C (GGR-deficient) primary human fibroblasts. Cells were irradiated in the G1 phase of the cell cycle, with two doses with equivalent levels of apoptosis (low and high), defined for each cell line. In the three cell lines, the low doses of UVB caused only a transient delay in progression to the S phase, whereas the high doses induced permanent cell cycle arrest. However, while accumulation of Mdm2 correlated well with the recovery from transcription inhibition at the low doses for normal and CS-B fibroblasts, for XP-C cells this protein was shown to be accumulated even at UVB doses that induced high levels of apoptosis. Thus, UVB-induced accumulation of Mdm2 is critical for counteracting p53 activation and apoptosis avoidance, but its effect is limited due to transcription inhibition. However, in the case of XP-C cells, an excess of unrepaired DNA damage would be sufficient to block S phase progression, which would signal to apoptosis, independent of Mdm2 accumulation. The data clearly discriminate DNA damage signals that lead to cell death, depending on the presence of UVB-induced DNA damage in replicating or transcribing regions.
Subject(s)
Fibroblasts/metabolism , Fibroblasts/radiation effects , G1 Phase/radiation effects , S Phase/radiation effects , Signal Transduction/radiation effects , Transcription, Genetic/radiation effects , Ultraviolet Rays , Blotting, Western , Cell Death/radiation effects , Cells, Cultured , Cockayne Syndrome/pathology , DNA Damage , DNA Repair/radiation effects , Dose-Response Relationship, Radiation , Fibroblasts/cytology , Humans , Kinetics , Proto-Oncogene Proteins c-mdm2 , Tumor Suppressor Protein p53/metabolism , Xeroderma Pigmentosum/pathologySubject(s)
Cockayne Syndrome/genetics , Codon, Nonsense , DNA Repair Enzymes/genetics , Transcription Factors/genetics , Brain/pathology , Cerebral Palsy/diagnosis , Cockayne Syndrome/diagnosis , Cockayne Syndrome/epidemiology , Cockayne Syndrome/pathology , Codon/genetics , Diagnostic Errors , Disease Progression , Dominican Republic/ethnology , Follow-Up Studies , Homozygote , Humans , Infant , Magnetic Resonance Imaging , Male , Phenotype , Sequence Analysis, DNAABSTRACT
Cockayne is a segmental progeroid syndrome that has autosomal recessive inheritance pattern. It is mainly characterized by Intrauterine growth retardation, severe postnatal growth deficiency, cachectic dwarfism, microcephaly, wizened face, sensorineural hearing loss, cataracts, dental caries, cardiac arrhythmias, hypertension, atherosclerosis, proteinuria, micropenis, renal failure, skeletal abnormalities, skin photosensitivity, decreased subcutaneous adipose tissue, cerebral atrophy, dementia, basal ganglia calcifications, ataxia and apraxia. It has a complex phenotype given by genetic heterogeneity. There are five gene responsible for this syndrome: CSA, CSB, XPB, XPD and XPG, in which various mutations have been found. The biochemical effect of these mutations includes dysfunctional protein of the repair system for oxidative damage to DNA, the complex coupled to transcription and the nucleotide excision repair system. Considering the role played for these proteins and its effects on clinical phenotype when they are deficient, we suggest that these genes might be candidates for analyzing susceptibility to common chronic degenerative diseases related to oxidative stress and aging.
Subject(s)
Cockayne Syndrome/genetics , DNA Damage , DNA Repair/genetics , Carbidopa/therapeutic use , Cockayne Syndrome/diagnosis , Cockayne Syndrome/drug therapy , Cockayne Syndrome/metabolism , Cockayne Syndrome/pathology , DNA Helicases/deficiency , DNA Helicases/genetics , DNA Helicases/physiology , DNA Repair Enzymes/deficiency , DNA Repair Enzymes/genetics , DNA Repair Enzymes/physiology , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , DNA-Binding Proteins/physiology , Diagnosis, Differential , Endonucleases/deficiency , Endonucleases/genetics , Endonucleases/physiology , Genes, Recessive , Genetic Predisposition to Disease , Genotype , Growth Disorders/diagnosis , Humans , Levodopa/therapeutic use , Mutation , Nuclear Proteins/deficiency , Nuclear Proteins/genetics , Nuclear Proteins/physiology , Oxidative Stress/genetics , Phenotype , Photosensitivity Disorders/diagnosis , Poly-ADP-Ribose Binding Proteins , Transcription Factors/deficiency , Transcription Factors/genetics , Transcription Factors/physiology , Xeroderma Pigmentosum Group D Protein/deficiency , Xeroderma Pigmentosum Group D Protein/genetics , Xeroderma Pigmentosum Group D Protein/physiologyABSTRACT
PURPOSE: To describe cataracts in classic and early onset Cockayne syndrome (CS). Classic CS typically has an onset after the first year of life; intrauterine growth failure and severe neurologic dysfunction from birth distinguishes the less common early onset CS from the classic form. METHODS: A complete ophthalmic evaluation was performed in four affected patients, one with the early onset and three with classic CS. RESULTS: We report cataract in all patients and glaucoma in one, the latter never previously reported in CS. CONCLUSION: CS should be considered in babies with low birth weight and congenital cataract.
Subject(s)
Cataract/complications , Cockayne Syndrome/complications , Adolescent , Cataract/genetics , Cataract/pathology , Cataract Extraction , Child , Child, Preschool , Cockayne Syndrome/genetics , Cockayne Syndrome/pathology , Female , Glaucoma/complications , Humans , MaleABSTRACT
Sister chromatid exchange (SCE) frequency and cell proliferation were examined in lymphocyte cultures from a group of newborns, a group of elderly subjects and from patients with syndromes who exhibit progeriform characteristics (progeria, Cockayne syndrome, Rothmund-Thomson syndrome and Christ-Siemens-Touraine syndrome) by using the bromodeoxyuridine incorporation differential staining technique. We observed a significantly increase in basal SCE frequency and a less intensive cell proliferation in cultures from elderly subjects than from newborns, as shown by the significant increase in percentage of cells in first generation simultaneous with a reduction of cells in more advanced generations. Lymphocyte cultures from each one of the patients studied also showed a decreased cell proliferation in relation to their respective control and to newborn cultures. Each of these syndromes showed higher baseline SCE levels than the control and than the newborn and elderly groups. Only the patient with progeria showed values similar to those for the elderly group. Thus, in addition to showing clinical characteristics similar to those observed during the normal aging process, these progeriform syndromes also show cytogenetic characteristics similar to those of older individuals.